Improving Antibiotic Timing in Febrile Neutropenia for Pediatric Oncology Patients with a Central Line

被引:2
|
作者
Roseland, Jenae [1 ]
机构
[1] Univ Iowa, Pediat, Iowa City, IA USA
关键词
pediatric; oncology; fever; neutropenia; antibiotic;
D O I
10.1177/1043454221992294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Febrile neutropenia in pediatric oncology patients is considered a medical emergency. This population is at risk for infection-related complications due to their immunocompromised state. The purpose of this evidence-based quality improvement project was to reduce the time in minutes from admission to antibiotic administration to within 60 min in at least 90% of pediatric oncology patients with a central line presenting with febrile neutropenia. Methods: An order set titled "FAST BREAK-Fever Neutropenia Admission" was created to expedite care during the first hour of admission, including labs, blood cultures, and a one-time STAT dose of intravenous cefepime. Education was provided to all providers and nursing staff on the unit through inservices, handouts, emails, and computer reminders. Results: Within three months from the FAST BREAK order set implementation, compliance for administering antibiotics within 60 min from admission occurred in 100% of admissions. Other outcomes included 100% compliance in provider utilization of the order set, reduction in the average time from admission to antibiotic administration, and cost reduction related to cefepime waste. Discussion: The FAST BREAK order set is now considered the standard of care in the Pediatric Cancer Center at the University of Iowa Stead Family Children's Hospital. Maintaining the expectation of prompt antibiotic administration for febrile neutropenia in pediatric oncology patients with a central line will improve patient care, reduce adverse outcomes in this vulnerable population, and correlate with national guidelines for antibiotic administration in febrile oncology patients.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 50 条
  • [11] Risk Factors for Readmission Following Febrile Neutropenia in Pediatric Oncology Patients
    McCormick, Meghan
    Richardson, Troy
    Rapkin, Louis
    Kalpatthi, Ram
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (04) : E496 - E501
  • [12] PROLONGED FEBRILE NEUTROPENIA: RISK FACTORS AND OUTCOME IN PEDIATRIC ONCOLOGY PATIENTS
    Alam, M. M.
    Qureshi, S.
    Matloob, R.
    Fadoo, Z.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S386 - S387
  • [13] PEGFILGRASTIM ADMINISTRATION TIMING AND ITS EFFECT ON FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS
    Mack, Joana
    Spray, Beverly
    Mack, Delanie
    Mason, Katherine
    Becton, David
    Bielamowicz, Kevin
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [14] EVALUATING EFFICACY OF AN EMPIRIC ANTIBIOTIC REGIMEN IN PEDIATRIC PATIENTS WITH FEBRILE NEUTROPENIA
    Knight, Tristan
    Gupte, Avanti
    Dulay, Kristopher
    Mitchell, Robert
    Salimnia, Hossein
    Wang, Zhihong Joanne
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [15] Timing of antibiotic administration and outcomes in patients with chemotherapy-induced febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 221 - 222
  • [16] TIME-TO-ANTIBIOTIC ADMINISTRATION AS A QUALITY OF CARE MEASURE IN PEDIATRIC FEBRILE NEUTROPENIA: A SURVEY OF PEDIATRIC ONCOLOGY CENTERS
    McCavit, Timothy
    Winick, Naomi
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 944 - 944
  • [17] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Orme, Lisa M.
    Babl, Franz E.
    Barnes, Chris
    Barnett, Peter
    Donath, Susan
    Ashley, David M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1427 - 1433
  • [18] Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients
    Alali, Muayad
    Prather, Cassandra
    Danziger-Isakov, Lara A.
    Kussin, Michelle L.
    Khalifeh, Malak
    Al Othman, Nashwan
    Bartlett, Allison H.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (06) : E702 - E709
  • [19] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Mathew, Jospeh L.
    INDIAN PEDIATRICS, 2014, 51 (08) : 659 - 660
  • [20] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Jospeh L. Mathew
    Ramandeep Singh Arora
    Janani Sankar
    Indian Pediatrics, 2014, 51 : 659 - 661